Phase 4
Completed N=284
Clinical Evaluation of Narrow Band Imaging Colonoscope
Colonic Neoplasms
Source: ClinicalTrials.gov NCT00628147 ↗
Enrolled (actual)
284
Serious AEs
0.0%
Results posted
Mar 2017
Primary outcomePrimary: Neoplasm Miss Rate — 12.6; 12.1 Miss rate percentage
◆ Published Evidence
Highly cited
157citations · ~9 / year
A randomised tandem colonoscopy trial of narrow band imaging versus white light examination to compare neoplasia miss rates.
Summary
The purpose of the study is to determine if colonoscopic examination using a colonoscope with a narrow band imaging light is more effective at detecting polyps compared to a colonoscope with standard full spectrum white light.
Linked Publications
-
A randomised tandem colonoscopy trial of narrow band imaging versus white light examination to compare neoplasia miss rates.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Neoplasm Miss Rate |
12.6; 12.1 | — |
| SECONDARY Neoplasm Detection Rates |
69; 66; 29; 31; 40; 35 | — |
| SECONDARY Completion of Examinations |
135; 141 | — |
| SECONDARY Procedure Complications |
0; 0 | — |
Eligibility Criteria
Inclusion Criteria
- referred for elective outpatient colonoscopy
Exclusion Criteria
- known inflammatory bowel disease
- personal or family history of polyposis syndrome
- referral for resection of a known lesion
Data sourced from ClinicalTrials.gov (NCT00628147) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.